awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39000587-A683990F-6106-4B2C-A90C-858B1B22E94E
Q39000587-A683990F-6106-4B2C-A90C-858B1B22E94E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39000587-A683990F-6106-4B2C-A90C-858B1B22E94E
Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversies.
P2860
Q39000587-A683990F-6106-4B2C-A90C-858B1B22E94E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39000587-A683990F-6106-4B2C-A90C-858B1B22E94E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d6198607910750d21c391acfffcb32bfd3fa5954
P2860
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.